Clinical Trials List
2023-10-31 - 2027-08-31
Phase III
Not yet recruiting7
Recruiting1
ICD-10C22.0
Liver cell carcinoma
ICD-10C22.2
Hepatoblastoma
ICD-10C22.3
Angiosarcoma of liver
ICD-10C22.4
Other sarcomas of liver
ICD-10C22.7
Other specified carcinomas of liver
ICD-10C22.8
Malignant neoplasm of liver, primary, unspecified as to type
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9155.0
Malignant neoplasm of liver, primary
-
-
Trial Applicant
QPS
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- 邱彥程 無
- Chih-Chieh Yen Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- Chiu Hung Chiu 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Hsueh-Chou Lai Digestive System Department
- Cheng-Yuan Peng Division of General Internal Medicine
- Wei-Fan Hsu Division of General Internal Medicine
- Hung-Wei Wang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chia-Hsun Hsieh 無
- 呂嘉偉 無
- Yi-Chung Hsieh 無
- 李勁樵 無
- 洪豪謙 無
- 吳宗翰 無
- 吳庭榕 無
- 林伯庭 無
- 李勁樵 無
- Kun-Ming Chan 無
- 周宏學 無
- 鄭志軒 無
- 洪豪謙 無
- Wei-Chen Lee 無
- 陳奎安 無
- 王瑜肇 無
- 李兆偉 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 李少武 無
- Sheng-Shun Yang 無
- 呂宜達 無
- YI-JU CHEN 無
- 吳峯旭 無
- 張碧倚 無
- CHUNG-HSIN CHANG 無
- 蔡炘儒 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 吳佩珊 無
- Tsung-Chieh Yang 無
- 李癸汌 無
- 黃惠君 無
- Pei-Chang Lee 無
- 陳蓉宣 無
- 呂學聖 無
- 陳宥任 無
- Chien-Wei Su 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JA-DER LIANG Division of General Internal Medicine
- Ming-Chih Ho Division of General Surgery
- Chien-Hung Chen Division of General Internal Medicine
- 吳志宏 Division of Radiology
- - - Division of Radiology
- 蘇東弘 Division of General Internal Medicine
- 何承懋 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
496 participants
